Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study

INTRODUCTION: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) improve hepatic dysfunction, although studies focusing on their underlying mechanisms are lacking, especially ones on dapagliflozin and empagliflozin. Here, we investigated the relationship between amelioration of hepatic dysfunction...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Ther
Main Authors: Lee, Paul Chi Ho, Gu, Yunjuan, Yeung, Man Yi, Fong, Carol Ho Yi, Woo, Yu Cho, Chow, Wing Sun, Tan, Kathryn, Lam, Karen Siu Ling
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5801241/
https://ncbi.nlm.nih.gov/pubmed/29322486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0355-3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker